Skip to main content
logo
Racura Oncology Ltd (ASX:RAC)
Australia flag Australia · Delayed Price · Currency is AUD
2.010
-0.020 (-0.99%)
Aug 7, 2026, 3:59 PM AEST

Racura Oncology Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Capitalization
390204311200311527
Market Cap Growth
89.49%-34.32%55.59%-35.78%-41.00%546.75%
Enterprise Value
369185297173274522
Last Close Price
2.001.181.821.231.953.67

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
112.2233.7864.2763.73439.481360.92
PB Ratio
16.5512.7516.977.848.6238.42
P/TBV Ratio
18.4215.1420.058.929.5052.37

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
EV/Sales Ratio
106.1930.6861.4355.32387.061346.52

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Debt / Equity Ratio
-0.89-0.85-0.94-0.84-0.93-0.68
Net Debt / EBITDA Ratio
2.673.081.292.113.071.53
Asset Turnover
0.150.320.210.100.030.04
Quick Ratio
18.159.429.2620.1623.7118.07
Current Ratio
18.3710.299.3220.4424.1020.24
Return on Equity (ROE)
-42.40%-27.89%-63.10%-32.22%-44.96%-65.32%
Return on Assets (ROA)
-21.91%-15.63%-36.41%-20.41%-27.05%-39.39%
Return on Capital Employed (ROCE)
-34.50%-29.40%-74.40%-41.10%-31.00%-46.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
-2.41%-2.34%-4.45%-4.97%-3.60%-1.20%
Buyback Yield / Dilution
-2.69%-4.81%-2.35%-4.83%-17.06%-22.86%